1. Home
  2. WT vs ANIP Comparison

WT vs ANIP Comparison

Compare WT & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo WisdomTree Inc.

WT

WisdomTree Inc.

HOLD

Current Price

$18.37

Market Cap

2.1B

Sector

Finance

ML Signal

HOLD

ANIP

ANI Pharmaceuticals Inc.

HOLD

Current Price

$82.19

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WT
ANIP
Founded
1985
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Bankers/Brokers/Service
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
1.8B
IPO Year
2011
1999

Fundamental Metrics

Financial Performance
Metric
WT
ANIP
Price
$18.37
$82.19
Analyst Decision
Hold
Strong Buy
Analyst Count
3
5
Target Price
$17.33
$110.00
AVG Volume (30 Days)
3.3M
291.7K
Earning Date
05-01-2026
05-08-2026
Dividend Yield
0.69%
N/A
EPS Growth
127.27
419.23
EPS
0.75
3.32
Revenue
$493,753,000.00
$206,547,000.00
Revenue This Year
$35.04
$21.01
Revenue Next Year
$8.68
$17.59
P/E Ratio
$23.27
$24.37
Revenue Growth
15.43
2.47
52 Week Low
$8.18
$56.71
52 Week High
$17.87
$99.50

Technical Indicators

Market Signals
Indicator
WT
ANIP
Relative Strength Index (RSI) 70.09 63.35
Support Level $13.07 $77.77
Resistance Level N/A $83.87
Average True Range (ATR) 0.74 2.77
MACD 0.37 0.52
Stochastic Oscillator 96.85 95.52

Price Performance

Historical Comparison
WT
ANIP

About WT WisdomTree Inc.

WisdomTree Inc is a financial innovator, offering a diverse suite of Exchange-traded products (ETPs), models and solutions, private market investments and digital asset-related products. It also offers digital products and services related to tokenized real world assets and stablecoins, including tokenized mutual funds (Digital Funds), as well as its institutional platform, WisdomTree Connect, and blockchain-native digital wallet, WisdomTree Prime. The company's products are distributed across various asset management industry channels, including banks, brokerage firms, registered investment advisers, institutional investors, private wealth managers and online brokers. The majority of the company's revenue is generated from advisory fees earned from ETPs.

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc is a diversified biopharmaceutical company. It is focused on developing, manufacturing, and commercializing therapeutics through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; and through its Generics and Brands businesses. The firm's product portfolio comprises Purified Cortrophin Gel, ILUVIEN, and YUTIQ (fluocinolone acetonide intravitreal implant), among others. Additionally, its Generics portfolio includes several products with a wide variety of indications. The company has two operating segments: Rare Disease and Brands, which derive maximum revenue, and Generics and Other. Geographically, it generates maximum revenue from the United States, followed by other markets.

Share on Social Networks: